Wnt modulates MCL1 to control cell survival in triple negative breast cancer.
Yang L, Perez AA, Fujie S, Warden C, Li J, Wang Y, Yung B, Chen YR, Liu X, Zhang H, Zheng S, Liu Z, Ann D, Yen Y.
Yang L, et al. Among authors: chen yr.
BMC Cancer. 2014 Feb 24;14:124. doi: 10.1186/1471-2407-14-124.
BMC Cancer. 2014.
PMID: 24564888
Free PMC article.
Clinical Trial.